• search
CDMO Services in Mexico CDMO Services in Mexico

CDMO Services in Mexico

Our manufacturing facility based out of Cuernavaca, Mexico is capable of handling small molecule APIs, Steroids and mPEG alcohol. The CDMO plant has a legacy of +15 years and is spread across 122,453 m2. The facility handles complex chemical synthesis and is designed to handle cryogenic processes. The installed production capacity per year is 3,300 tons and all operations are carried out in closed conditions.    

The facility is inspected by: COFEPRIS US FDA KFDA EDQM Ministry of Industry and Trade of the Russian Federation MoH Romania

Contact Us

Manufacturing Plant of Cuernavaca, Mexico

Why Aurigene Services?

18 years of experience

Experience gained from 100+ discovery programmes

World-class infrastructure

Track record of delivering 8+ IND candidates

Flexible working models

Quick turnaround time

Capabilities to apply multiple modalities

Seamless integration capabilities with Biology as well as CDMO services

Integrated project management

Expertise in various therapeutic modalities

Services

Aurigene Pharmaceutical Services Limited is a leading contract research, development and manufacturing organization (CDMO) providing end-to-end solutions. With a strong legacy of services in discovery, development and manufacturing we are ideally positioned to serve global pharma and specialty companies worldwide.

Small Molecules manufacturing facility
Continuous Flow Chemistry: A Game-Changer for Pharmaceutical Production

Continuous Flow Chemistry: A Game-Changer for Pharmaceutical Production

Fig 1:Schematic diagram of continuous flowFlow chemistry, also known as continuous flow chemistry, involves the continuous movement of reactants through a reactor to produce products. Unlike traditional batch chemistry, where reactants are mixed in a single vessel and processed in discrete batches, flow chemistry uses a continuous stream of reactants and intermed...

Read More
CDMO white paper

Advancement in personalized medicine and how the CRDMO industry is part of the solution

Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role in enabli...

Read More
Anti-infective drug discovery

Anti-Infective Drug Discovery

Objective & Challenges: Objective was to identify an optimized anti-bacterial lead molecule with in vivo efficacy in relevant infection models an acceptable safety profile, and a patentable series.      Challenge was to develop a more efficacious compound than the reference standard.Study design: Compounds were designed and synth...

Read More

A simple RP-HPLC method development and verification of the Dissolution of Bromelain-A Complex mixture of proteolytic enzymes, in delayed release tablets

2024

Bromelain is a complex natural mixture of proteolytic enzymes derived from pineapple (Ananas cosmosus), which has good therapeutic properties. Bromelain can be found in all tissues of pineapple plants, including the stem, fruit, and leaves. Bromelain plays an important role in the treatment of many diseases such as soft tissue inflammation and edema, deep derma, ...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack